These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3728178)

  • 1. Urinary oxipurinol-1-riboside excretion and allopurinol-induced oroticaciduria.
    Reiter S; Löffler W; Gröbner W; Zöllner N
    Adv Exp Med Biol; 1986; 195 Pt A():453-60. PubMed ID: 3728178
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of dietary purine restriction, allupurinol, and oxipurinol on urinary excretion of ultraviolet-absorbing compounds.
    Kelley WN; Wyngaarden JB
    Clin Chem; 1970 Aug; 16(8):707-13. PubMed ID: 5474201
    [No Abstract]   [Full Text] [Related]  

  • 3. Allopurinol-1-riboside formation and HGPRT-deficiency.
    Reiter S; Löffler W; Gröbner W; Zöllner N
    Adv Exp Med Biol; 1986; 195 Pt A():447-51. PubMed ID: 3728177
    [No Abstract]   [Full Text] [Related]  

  • 4. On the metabolism of allopurinol. Formation of allopurinol-1-riboside in purine nucleoside phosphorylase deficiency.
    Reiter S; Simmonds HA; Webster DR; Watson AR
    Biochem Pharmacol; 1983 Jul; 32(14):2167-74. PubMed ID: 6409116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purine and pyrimidine metabolism in hereditary oroticaciduria during a 15 year follow-up study.
    Webster DR; Simmonds HA; Potter CF; Becroft DM
    Adv Exp Med Biol; 1979; 122B():203-8. PubMed ID: 546145
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of dietary purines on allopurinol metabolism and allopurinol induced oroticaciduria.
    Reiter S; Löffler W; Gröbner W; Zöllner N
    Adv Exp Med Biol; 1984; 165 Pt A():323-6. PubMed ID: 6720397
    [No Abstract]   [Full Text] [Related]  

  • 7. Simultaneous determination of plasma and urinary uric acid, xanthine, hypoxanthine, allopurinol, oxipurinol, orotic acid, orotidine and creatinine by high-performance liquid chromatography.
    Miyazaki H; Matsunaga Y; Yoshida K; Arakawa S; Hashimoto M
    J Chromatogr; 1983 May; 274():75-85. PubMed ID: 6874855
    [No Abstract]   [Full Text] [Related]  

  • 8. The allopurinol loading test in detecting obligate heterozygotes for OCT deficiency.
    Sebesta I; Krijt J; Fairbanks LD; Simmonds HA
    J Inherit Metab Dis; 1994; 17(1):133-4. PubMed ID: 8051924
    [No Abstract]   [Full Text] [Related]  

  • 9. The urinary excretion of orotic acid and orotidine, measured by an isotope dilution assay.
    Tax WJ; Veerkamp JH; Schretlen ED
    Clin Chim Acta; 1978 Dec; 90(3):217-23. PubMed ID: 365397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The influence of allopurinol on purine- and pyrimidinesynthesis (author's transl)].
    Gröbner W; Zöllner N
    Klin Wochenschr; 1978 Mar; 53(16):255-60. PubMed ID: 682520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and metabolism of allopurinol riboside.
    Shapiro TA; Were JB; Danso K; Nelson DJ; Desjardins RE; Pamplin CL
    Clin Pharmacol Ther; 1991 May; 49(5):506-14. PubMed ID: 2029827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allopurinol-induced orotidinuria. A test for mutations at the ornithine carbamoyltransferase locus in women.
    Hauser ER; Finkelstein JE; Valle D; Brusilow SW
    N Engl J Med; 1990 Jun; 322(23):1641-5. PubMed ID: 2342523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of dose and age on the response of the allopurinol test for ornithine carbamoyltransferase deficiency in control infants.
    Riudor E; Arranz JA; Rodés M; Rubio V; Sentís M; Burlina AB
    J Inherit Metab Dis; 2000 Nov; 23(7):662-8. PubMed ID: 11117427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allopurinol challenge test in children.
    Burlina AB; Ferrari V; Dionisi-Vici C; Bordugo A; Zacchello F; Tuchman M
    J Inherit Metab Dis; 1992; 15(5):707-12. PubMed ID: 1434508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oxipurinol and allopurinol riboside on whewellite crystallization: in vitro and in vivo observations.
    Finlayson B; Burns J; Smith A; Du Bois L
    Invest Urol; 1979 Nov; 17(3):227-9. PubMed ID: 500322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orotidine accumulation in human erythrocytes during allopurinol therapy: association with high urinary oxypurinol-7-riboside concentrations in renal failure and in the Lesch-Nyhan syndrome.
    Simmonds HA; Reiter S; Davies PM; Cameron JS
    Clin Sci (Lond); 1991 Mar; 80(3):191-7. PubMed ID: 1850677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary purines, pyrimidines and nucleosides in uridine-treated orotic aciduria.
    Mill GC
    Clin Chim Acta; 1988 Jun; 174(3):337-43. PubMed ID: 3390959
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolic studies of high doses of allopurinol in humans.
    Nelson DJ; Elion GB
    Adv Exp Med Biol; 1984; 165 Pt A():167-70. PubMed ID: 6720373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of allopurinol challenge: sample purification, protein intake control, and the use of orotidine response as a discriminative variable improve performance of the test for diagnosing ornithine carbamoyltransferase deficiency.
    Arranz JA; Riudor E; Rodés M; Roig M; Climent C; Rubio V; Sentís M; Burlina A
    Clin Chem; 1999 Jul; 45(7):995-1001. PubMed ID: 10388475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quick cancer test developed.
    Lund AE
    J Am Dent Assoc; 1998 Aug; 129(8):1080, 1082. PubMed ID: 9715008
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.